Tryngolza Injection, Solution
Product Images NDC 71860-101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Tryngolza (NDC 71860-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ionis Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Tryngolza 02)
This text provides data on the effect of TRYNGOLZA 80 NG compared to placebo on the change in fasting triglycerides levels over a period of 12 months. The values in mg/dL are presented for baseline, month 1, month 3, month 6, month 9, and month 12 visits. The results show a different trend in triglyceride levels between the placebo and TRYNGOLZA 80 NG groups over time.*
Figure 3 (Tryngolza 03)
This text provides information on the levels of fasting triglycerides measured in mg/dL over time for individuals in a placebo group and a group taking a medication called TRYNGOLZA 80 MG. The data is shown for baseline, month 1, month 3, month 6, month 9, and month 12 visits, with corresponding median values illustrated in a graph.*
Figure 4 (Tryngolza 04)
Figure 5 (Tryngolza 05)
Figure 6 (Tryngolza 06)
Figure 7 (Tryngolza 07)
Figure 8 (Tryngolza 08)
Figure 9 (Tryngolza 09)
Figure 10 (Tryngolza 10)
Figure 11 (Tryngolza 11)
Figure 12 (Tryngolza 12)
Figure 13 (Tryngolza 13)
Figure 14 (Tryngolza 14)
Figure 15 (Tryngolza 15)
Figure 16 (Tryngolza 16)
Figure 17 (Tryngolza 17)
Figure 18 (Tryngolza 18)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.